Trial Site Detail

 

Drug:
Pazopanib (Votrient)
Trial:
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Department of Oncology, St Olav Hospital

     
Trondheim , N-7006
Norway

 

Principal Investigator:
Heidi Knobel, MD
Contact:
Heidi Knobel, MD +47 73867830 heidi.knobel@stolav.no
Activation Status of this Site:
Closed
Notes about this Site:
Department of Oncology, St Olav Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.